Table 1:
Baseline clinical and radiographic characteristics of patients based on prior statin treatment
| Baseline Characteristics | Prior Statin (n = 96) | No Prior Statin (n = 322) | P Value |
|---|---|---|---|
| Age (yr) (median) (IQR) | 73 (14) | 66 (24) | <.001 |
| Sex (% male) | 68% (65/96) | 58% (187/322) | .09 |
| Smoking | 15% (14/96) | 15% (49/322) | .87 |
| Hypertension (%) | 73% (70/96) | 50% (159/322) | <.001 |
| Diabetes mellitus (%) | 19% (18/96) | 12% (39/322) | .044 |
| Prior ASA treatment (%) | 65% (62/96) | 22% (71/322) | <.001 |
| Symptomatic carotid diseasea | 19% (18/96) | 7% (21/322) | .001 |
| Symptomatic intracranial diseaseb | 12% (11/96) | 21% (67/322) | .174 |
| Positive CTA findingc | 31% (30/96) | 27% (88/322) | .45 |
| DWI-positive | 64% (61/96) | 55% (177/322) | .08 |
| DWI infarct volume (mL) (median) (IQR) | 1.0 (2.5) | 1.1 (4) | .56 |
Note:—ASA indicates aspirin.
a
Symptomatic carotid disease: extracranial carotid stenosis of ≥50%.
b
Symptomatic intracranial disease: symptomatic intracranial vascular occlusion or stenosis of ≥50%.
c
Positive CTA finding: relevant intra- or extracranial occlusion or stenosis of ≥50%.